Moreover, celecoxib administration significantly increased the infiltration of CD8+ CTLs, and it also reduced Foxp3+ Tregs, CD68+ TAMs, and PD‐L1 expression in rat HCC tissues during epirubicin therapy. Here, CD8A is linked to hepatocellular carcinoma.